Flucytosine Capsules, USP are indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.

Flucytosine Capsules, USP
  • Compare to
    Ancobon®*
Inactive Ingredients

Capsule fill: Corn starch, lactose monohydrate and talc.

The imprinting ink for both the 250 mg and 500 mg capsules contain black iron oxide.

The 250 mg capsule shell contains FD&C Yellow No.6, FD&C Green No. 3, D&C Yellow No. 10, titanium dioxide, sodium lauryl sulfate and gelatin.

The 500 mg capsule shell contains iron oxide yellow, iron oxide black, titanium dioxide, carboxymethylcellulose, sodium lauryl sulfate and gelatin.

*Ancobon® is a registered trademark of Valeant Pharmaceuticals International, Inc.

Flucytosine Capsules, USP (250 mg)

  • Package size
    30ct
  • Rating
    AB
  • Strength
    250 mg
  • NDC Code
    42794-0009-08
Flucytosine Capsules, USP (250 mg)

Flucytosine Capsules, USP (500 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    500 mg
  • NDC Code
    42794-0010-08
Flucytosine Capsules, USP (500 mg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.